Reason | Antihypertensive treatment status | Suspected classification |
- Office-based blood pressures 10 mmHg or less below the patient's goal (eg, systolic pressure 120 to 129 mmHg)
| Not on treatment | Masked hypertension |
- Office-based blood pressures below the patient's goal plus any of the following:
- Elevated atherosclerotic cardiovascular disease risk (eg, 10-year atherosclerotic cardiovascular disease risk >10%)
- Chronic kidney disease
- Diabetes mellitus
- Evidence of new or worsening end-organ damage (eg, prior atherosclerotic cardiovascular event, heart failure, left ventricular hypertrophy, hypertensive retinopathy)
| On treatment | Masked uncontrolled hypertension |
- Office-based blood pressures above the patient's goal (but <180/120 mmHg) despite a 3-month trial of lifestyle modifications, and no evidence of hypertensive end-organ damage
| Not on treatment | White coat hypertension |
- Office-based blood pressures above the patient's goal
| On a minimum of 3 medications | White coat effect |
- Office-based blood pressures at or above the patient's goal with symptoms of hypotension (eg, lightheadedness, falls) at home or work
| On treatment | White coat effect |
- Labile office-based blood pressures
| Not on treatment or on treatment | All of the above |